Current therapies and investigational drugs for peripheral arterial disease

Jun Ichi Suzuki, Munehisa Shimamura, Hiroyuki Suda, Kouji Wakayama, Hidetoshi Kumagai, Yuichi Ikeda, Hiroshi Akazawa, Mitsuaki Isobe, Issei Komuro, Ryuichi Morishita

Research output: Contribution to journalArticle

20 Scopus citations

Abstract

Peripheral artery disease (PAD) is associated with elevated morbidity and mortality with cardiovascular (CV) disease. The guideline recommends smoking cessation and antiplatelet/antithrombotic drugs for asymptomatic and symptomatic PAD patients. It also recommends that PAD patients with critical limb ischemia (CLI) should be considered to receive endovascular and open surgical treatment for limb salvage. Although PAD patients with CLI receive these treatments, they are sometimes unable to deliver sufficient blood flow to eliminate their symptoms. Thus specific strategies are needed to promote enough blood flow. To establish the effective method, many investigations have been performed using cell-based therapy. Endothelial progenitor cells, mononuclear cells and mesenchymal stem cells have been well investigated in clinical settings. To induce angiogenesis, vascular endothelial growth factor, fibroblast growth factor and hepatocyte growth factor (HGF) have also been transfected in PAD patients. Among them, HGF is the most promising factor because it can induce angiogenesis without the induction of vascular inflammation and increased permeability. In this review article, we summarize current treatments and investigational drugs of PAD.

Original languageEnglish (US)
Pages (from-to)183-191
Number of pages9
JournalHypertension Research
Volume39
Issue number4
DOIs
StatePublished - Apr 1 2016

Keywords

  • cell therapy
  • gene therapy
  • hepatocyte growth factor

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Current therapies and investigational drugs for peripheral arterial disease'. Together they form a unique fingerprint.

  • Cite this

    Suzuki, J. I., Shimamura, M., Suda, H., Wakayama, K., Kumagai, H., Ikeda, Y., Akazawa, H., Isobe, M., Komuro, I., & Morishita, R. (2016). Current therapies and investigational drugs for peripheral arterial disease. Hypertension Research, 39(4), 183-191. https://doi.org/10.1038/hr.2015.134